Oct-3/4 dose dependently regulates specification of embryonic stem cells toward a cardiac lineage and early heart development

Dev Cell. 2006 Oct;11(4):535-46. doi: 10.1016/j.devcel.2006.07.013.

Abstract

The transcriptional mechanisms underlying lineage specification and differentiation of embryonic stem (ES) cells remain elusive. Oct-3/4 (POU5f1) is one of the earliest transcription factors expressed in the embryo. Both the pluripotency and the fate of ES cells depend upon a tight control of Oct-3/4 expression. We report that transgene- or TGFbeta-induced increase in Oct-3/4 mRNA and protein levels in undifferentiated ES cells and at early stages of differentiation triggers expression of mesodermal and cardiac specific genes through Smad2/4. cDNA antisense- and siRNA-mediated inhibition of upregulation of Oct-3/4 in ES cells prevent their specification toward the mesoderm and their differentiation into cardiomyocytes. Similarly, Oct-3/4 siRNA injected in the inner cell mass of blastocysts impairs cardiogenesis in early embryos. Thus, quantitative Oct-3/4 expression is regulated by a morphogen, pointing to a pivotal and physiological function of the POU factor in mesodermal and cardiac commitments of ES cells and of the epiblast.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blastocyst / cytology
  • Blastocyst / metabolism
  • Cell Lineage
  • Gene Expression Regulation, Developmental*
  • Heart / growth & development*
  • Immunohistochemistry
  • In Situ Hybridization
  • Mice
  • Microinjections
  • Myocytes, Cardiac / cytology*
  • Myocytes, Cardiac / metabolism
  • Octamer Transcription Factor-3 / genetics
  • Octamer Transcription Factor-3 / metabolism*
  • Organ Culture Techniques
  • RNA, Messenger / biosynthesis
  • RNA, Small Interfering / metabolism
  • Stem Cells / cytology*
  • Stem Cells / physiology*

Substances

  • Octamer Transcription Factor-3
  • Pou5f1 protein, mouse
  • RNA, Messenger
  • RNA, Small Interfering